Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP
Clinical trial NCT02166476 · COMPLETED
Trial details
- NCT number
- NCT02166476
- Sponsor
- Melinta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-11-20
- Primary completion
- 2016-04-28
- Enrollment
- 550
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.